Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Bond et al said that nasal fluticasone propionate caused benign
intracranial hypertension in a 13 year old boy with a history of
Crohn's disease and subsequently reported this to the Committee on
Safety of Medicines.1 We have numerous problems with this
hypothesis. Firstly, Bond et al did not confirm the diagnosis of
intracranial hypertension as the cerebrospinal fluid pressure, which
should be markedly raised, was not measured on any
occasion.2 Their conclusions can thus at best be based only on papilloedema, headache, and backache.
The boy was seen by specialists from the ear, nose, and throat
department, but no mention was made of the presence or absence of the
otological manifestations, which include objective pulsatile tinnitus
and low frequency hearing loss, which can be the major or only
manifestation of this syndrome.3 Other recognised
associated conditions were not excluded, such as hypervitaminosis A,
systemic lupus erythromatosis, hypothyroidism and its